Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @juliacowens
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @juliacowens
-
Only 3 public companies in Michigan have 50% or greater female board members... GM, Taubman Centers and Millendo.
#diversity@freep@millendotx@GM@TaubmanCentershttps://twitter.com/millendotx/status/1221822537102958593 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Really enjoyed listening to
@ldtimmerman interview fellow Ann Arbor biotech CEO, Tim Mayleben on The Long Run. I’ve known Tim a long time but still learned a lot about him and @EsperionInc. Check it out.https://timmermanreport.com/2020/01/a-new-cholesterol-lowering-drug-at-a-low-price-tim-mayleben-on-the-long-run/ …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Not a bad way to start JPM week.
#sunrise#JPM20pic.twitter.com/coIa5DlkMK
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Headed to my 21st JPMorgan conference in SF. My first was 1999 when it was H&Q - have only missed one since. It’s exhausting & I usually lose my voice but I wouldn’t miss it. Great for maintaining contacts, seeing friends & getting the industry pulse as we start the year.
#JPM20Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Thanks to
#JPM20 starting later than usual this year, I’m home to celebrate my son’s birthday for the first time in 14 years!@zingermans cinnamon rolls before school it is.#happybirthday#wheredidthetimego#workingmompic.twitter.com/BiP9Mt5uwW
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
More amazing teammates to tag...
@AdamDGridley@obeske@spencerdguthrie@75hab@immunegirl@kjacny@NancyAHong@danbiobrit@senthilsundaram@UcianeScarlettPrikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
I finally captured thoughts I’ve had since returning from Tanzania having climbed Mt Kilimanjaro with 26 amazing people, to whom this post is dedicated.
@ldtimmerman@Ptipirneni@Bobmorevc@ZweifachSanford@lesleystolz@nkjellson@ksbosley@SutroBioBillhttps://timmermanreport.com/2020/01/three-lessons-for-business-ahead-of-jpm-from-the-kilimanjaro-climb-to-fight-cancer/ …Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Julia Owens proslijedio/la je Tweet
Proud of UM & our spin-off MILLENDO as it extends beyond adrenal to other rare endocrine diseases-ie PWS. Did you know “MILLENDO” pays homage to benefactor of UM Endocrine Oncology Program, MILL-ie Schembechler & its focus on rare ENDO-crine disordershttps://labblog.uofmhealth.org/lab-report/drug-trial-seeking-first-ever-treatment-for-dangerous-side-effect-of-prader-willi …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Thank you
@PharmExec for a great conversation about the importance of planning for challenges and being ready to adopt new strategies to ensure continued growth.@millendotx http://www.pharmexec.com/episode-46-persistence-and-planning-pays …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
I am so pleased to welcome Geoff Nichol, CMO of BioMarin, to the board of
@millendotx. I’m honored have his depth of drug development, rare disease and strategic leadership experience as the company enters 2020 with many exciting opportunities ahead.https://www.businesswire.com/news/home/20191219005053/en/Geoff-Nichol-Appointed-Millendo-Therapeutics-Board-Directors …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Congratulations to
@carol_gallagher on receipt of the Duane Roth Distinguished Contribution Award for Life Sciences tonight at the 2019 Innovation Awards celebrating the leaders of the Southern California innovation economy.pic.twitter.com/oKwseY7K73
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Julia Owens proslijedio/la je Tweet
Celebrating completion of recruitment for our pivotal study of livoletide in
#PWS, a step forward for patients & families struggling with#PWS, and grateful to all investigators involved for their commitment and dedication https://investors.millendo.com/news-releases/news-release-details/millendo-therapeutics-completes-patient-recruitment-pivotal …pic.twitter.com/PlmJKLKfu0
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
For me this rings quite true. If I had not spent a decade after college in the SF Bay Area building connections, I don’t think it would have been possible for me to build a company in Michigan as a female founder and first time CEO.https://www.statnews.com/2019/10/31/social-connections-first-science-second/?utm_source=STAT+Newsletters&utm_campaign=f2795dadd6-RO_COPY_03&utm_medium=email&utm_term=0_8cab1d7961-f2795dadd6-149597133 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Really enjoying time in New Orleans with the
#PWS community for the@fpwr Research Symposium. Dr. Diane Stafford (@Stanford) discussing US Prevelance, Mortality and Comorbidity Burdens of PWS is one of 6 different@millendotx presentations today.pic.twitter.com/ayoCLp1lHx
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Julia Owens proslijedio/la je Tweet
A phase 2 study of livoletide showed meaningful decreases in hyperphagia. A new study is now enrolling ages 8 to 65 to evaluate its effects on hyperphagia, food related bevharios and body composition.https://fpwr.us/2ZgGJRC
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
I’m proud to be among the biopharma leaders pushing for reconsideration of a policy that would endanger patients receiving life-saving medical treatment in the US.https://www.biocentury.com/bc-extra/politics-policy/2019-09-04/us-reconsidering-deportation-orders-patients-receiving-medical- …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Julia Owens proslijedio/la je Tweet
VUMC is among some 35 sites worldwide running a clinical trial of the drug livoletide for people w/
#Prader-Willi syndrome. The hope is that livoletide will reduce the insatiable hunger from PWS, which typically leads to excess eating & obesity. http://spr.ly/6015E7JdN pic.twitter.com/130tuY0Zbw
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
So pleased and honored to have such experienced, strategic, hard-working and humble leaders like Tamara and Ryan on the leadership team at Millendo!https://twitter.com/millendotx/status/1163823489012424704 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
What an incredible experience climbing Mt Kilimanjaro with
@climbtofight and 26 phenomenal teammates. We’ve raised over $1.5M for cancer research at@fredhutch but have also forged deep friendships and memories along the way. Thank you to everyone involved!pic.twitter.com/z80KjXPxRc
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Julia Owens proslijedio/la je Tweet
THANK YOU to Team Kili! Over $1.5 million raised for lifesaving research at Fred Hutch. This team of pharmaceutical and biotech executives are climbing Mt Kilimanjaro, the tallest peak in Africa and one of the “7 Summits” to fund a cure.
@ldtimmerman@Veracyte@fredhutchpic.twitter.com/nkdoFROUjY
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.